SCHEMBL120211

SCHEMBL120211

CC1(C)OB(c2ccc(B3OC(C)(C)C(C)(C)O3)s2)OC1(C)C

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LPL P06858 13/20 0.42
LIPG Q9Y5X9 13/20 0.42
P2RX7 Q99572 1/20 0.38
MAPK1 P28482 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA12 O43570 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
CA5B Q9Y2D0 1/20 0.35
F11 P03951 1/20 0.34
USP30 Q70CQ3 1/20 0.33
SNCA P37840 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL390494 0.89 LPL (0.40) LPLLIPGP2RX7MAPK1CA1
SCHEMBL30846 0.87 LPL (0.37) LPLLIPGP2RX7MAPK1CA1
SCHEMBL17122542 0.86 LPL (0.36) LPLLIPGP2RX7
SCHEMBL16001682 0.85 LPL (0.36) LPLLIPGP2RX7MAPK1CA1
SCHEMBL5892452 0.85 LPL (0.36) LPLLIPGP2RX7MAPK1CA1
SCHEMBL14854211 0.85 LPL (0.36) LPLLIPGP2RX7MAPK1CA1
SCHEMBL14332445 0.85 LPL (0.43) LPLLIPGP2RX7MAPK1CA1
SCHEMBL2400910 0.85 LPL (0.36) LPLLIPGP2RX7MAPK1CA1
SCHEMBL15257597 0.83 LPL (0.38) LPLLIPGP2RX7MAPK1CA1
SCHEMBL19156303 0.83 LPL (0.33) LPLLIPGP2RX7MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129207-A1 SQUARIC ACID-BASED POLYMERS, THEIR MANUFACTURING PROCESSES AND THEIR USES HYDRO-QUéBEC (CA) 2025-04-24 US disclosed
US-12215190-B2 Squaric acid-based polymers, their manufacturing processes and their uses HYDRO-QUéBEC (CA) 2025-02-04 US disclosed
US-12031128-B2 Rapid design, build, test, and learn technologies for identifying and using non-viral carriers BATTELLE MEMORIAL INSTITUTE (US) 2024-07-09 US disclosed
US-20240117339-A1 RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS BATTELLE MEMORIAL INSTITUTE 2024-04-11 US disclosed
EP-4320233-A1 RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS Battelle Memorial Institute (US) 2024-02-14 EP disclosed
US-20230235388-A1 COMPOSITIONS AND METHODS FOR SEQUENCING USING AT LEAST ALTERING ELECTRICAL CHARACTERISTICS OF BRIDGES BETWEEN ELECTRODES ILLUMINA SINGAPORE PTE. LTD. (SG) 2023-07-27 US disclosed
US-20230235388-A1 COMPOSITIONS AND METHODS FOR SEQUENCING USING AT LEAST ALTERING ELECTRICAL CHARACTERISTICS OF BRIDGES BETWEEN ELECTRODES ILLUMINA SINGAPORE PTE. LTD. (SG) 2023-07-27 US disclosed
EP-2435497-B1 POLYCYCLIC DITHIOPHENES CLAP CO LTD (KR) 2023-07-05 EP disclosed
US-11569530-B2 Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives ENEVATE CORPORATION (US) 2023-01-31 US disclosed
EP-2825587-B1 CONJUGATED POLYMERS RAYNERGY TEK INC (TW) 2022-11-23 EP disclosed
US-20070282094-A1 Silole-based polymers and semiconductor materials prepared from the same USA AS REPRESENTED BY THE ADMINISTRATOR OF THE NASA 2007-12-06 US disclosed
US-20070282094-A1 Silole-based polymers and semiconductor materials prepared from the same USA AS REPRESENTED BY THE ADMINISTRATOR OF THE NASA 2007-12-06 US disclosed
WO-2007133705-A2 SILOLE-BASED POLYMERS AND SEMICONDUCTOR MATERIALS PREPARED FROM THE SAME NORTHWESTERN UNIVERSITY (US) 2007-11-22 WO disclosed
US-20070045592-A1 Process for the polymerisation of thiophene or selenophene compounds FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-03-01 US disclosed
US-20070045592-A1 Process for the polymerisation of thiophene or selenophene compounds FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-03-01 US disclosed
US-20070045592-A1 Process for the polymerisation of thiophene or selenophene compounds FLEXENABLE TECHNOLOGY LIMITED (GB) 2007-03-01 US disclosed
EP-1754736-A1 Process for the polymerisation of thiophene or selenophene derivatives Merck Patent GmbH (DE) 2007-02-21 EP disclosed
EP-1754736-A1 Process for the polymerisation of thiophene or selenophene derivatives Merck Patent GmbH (DE) 2007-02-21 EP disclosed
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst MITSUBISHI RAYON CO., LTD. (JP) 2005-07-07 US disclosed
EP-1481978-A1 PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST Mitsubishi Rayon Co., Ltd. (JP) 2004-12-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12031128-B2 Rapid design, build, test, and learn technologies for identifying and using non-viral carriers PHAX, POLRMT, RFTN1 LPL 3809/4885LIPG 2658/4885P2RX7 3768/4885
US-20050148775-A1 Process for production of heteroaryl-type boron compounds with iridium catalyst PIN4, IPO5, HLCS LPL 2994/4885LIPG 4113/4885P2RX7 854/4885
US-20240117339-A1 RAPID DESIGN, BUILD, TEST, AND LEARN TECHNOLOGIES FOR IDENTIFYING AND USING NON-VIRAL CARRIERS PHAX, POLRMT, RFTN1 LPL 3809/4885LIPG 2658/4885P2RX7 3768/4885
US-11569530-B2 Silicon-based energy storage devices with functional thiophene compounds or derivatives of thiophene containing electrolyte additives TST, SELENOI, SELE LPL 2374/4885LIPG 1914/4885P2RX7 2642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.